A detailed history of Catalina Capital Group, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Catalina Capital Group, LLC holds 8,098 shares of JNJ stock, worth $1.3 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares
8,098
Previous 6,625 22.23%
Holding current value
$1.3 Million
Previous $968 Million 35.53%
% of portfolio
0.44%
Previous 0.36%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$145.48 - $167.38 $214,292 - $246,550
1,473 Added 22.23%
8,098 $1.31 Billion
Q2 2024

Jul 24, 2024

SELL
$144.38 - $157.78 $220,035 - $240,456
-1,524 Reduced 18.7%
6,625 $968 Million
Q1 2024

May 03, 2024

BUY
$155.22 - $162.74 $668,842 - $701,246
4,309 Added 112.21%
8,149 $1.29 Billion
Q4 2023

Apr 30, 2024

BUY
$145.6 - $158.88 $559,104 - $610,099
3,840 New
3,840 $602 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $420B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Catalina Capital Group, LLC Portfolio

Follow Catalina Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalina Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Catalina Capital Group, LLC with notifications on news.